PathGroup is an industry leader in the rapidly evolving quest to identify and understand disease at the genetic level. We are focused on delivering the most precise, expert diagnostic information to our physician partners, creating opportunities for personalized medicine and targeted therapies that lead to the best possible patient outcomes.

As the molecular pathology field continues to grow and advance in all directions, new techniques and tests are announced every day. PathGroup is not only selective about our testing menu, but careful to utilize only proven, clinically relevant, advanced technology, so our physician partners and their patients always receive results they can act on with confidence.

Our full service laboratory provides examination and interpretation of specimens for diagnostic, prognostic, predictive and residual disease testing within the following areas:

PathGroup’s core technologies include:

iPath® Comprehensive Assessment

Additionally, PathGroup offers the iPath® Comprehensive Assessment.  iPath includes clinical pathology evaluation, bone marrow and/or blood morphology, flow cytometry, cytogentics and/or FISH, and PCR as medically necessary.  A consultative review and correlation with all prior findings is performed by a PathGroup Hematopatholgist.  iPath provides a concise summary report correlation of all technologies for easy review.

The PathGroup Advantage

Our molecular pathology division provides fast, accurate results to health professionals making vital treatment decisions. Our physician-centric, patient focused approach includes:

 

In keeping with our commitment to excellence in pathology, we maintain certifications with the State, College of American Pathologists (CAP) and the Joint Commission as well as the Laboratory Improvement Act (CLIA). Our physician group provides volunteer surveyors for the Laboratory Accreditation Program of the CAP.